Gilead Sciences, Inc. (Nasdaq: GILD) today announced details of new clinical and real-world data from its innovative HIV treatment and prevention portfolio and research pipeline that will be presented ...

The running themes of treating and preventing HIV will be highlighted early in the plenary session held on Monday morning.

Around the same time, estimates of resources required to meet proposed goals were calculated and published. Prevention and treatment, which received equitable attention in the original UN language, ...

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced its program for the upcoming 25th International AIDS Conference (AIDS 2024), taking place in Munich, Germany ...

Last weekend, communities nationwide marked Black HIV/AIDS Awareness Day, or NBHAAD, during an urgent time for people living with the disease and those who support them. More than four decades after ...

By Chris Takudzwa Muronzi HARARE, Feb 19 (Reuters) - Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the country one of the first ...

A Q&A With Shauna Applin, ARNP. AJMC: Despite substantial therapeutic advances since the 1980s, the US is not on pace to achieve the goals of the Ending the HIV Epidemic (EHE) public health initiative ...

The San Francisco Department of Public Health says the Centers for Disease Control is pulling $8 million in grants which will largely impact HIV treatment and prevention services. The White House said ...

The Illinois Department of Public Health announced in early February that the Trump administration cut $100 million in ...

South Africa will launch Lenacapavir, a six-month HIV prevention injection, in six provinces, targeting all HIV-negative ...

UNAIDS welcomes the passing into law by the President of Benin Patrice Talon of Law 2026-02 on 9 February 2026. The law focuses on HIV prevention, management and will accelerate progress towards ...